<p>Aqueous-based, ready to use topotecan-containing formulations for parenteral use having extended stability are disclosed. The formulations are surprisingly free of precipitated degradation products such as 10-hydroxycamptothecin (10-HCPT) after periods of up to 1 year or greater.</p>
申请公布号
EP2259776(A1)
申请公布日期
2010.12.15
申请号
EP20090716836
申请日期
2009.02.27
申请人
EAGLE PHARMACEUTICALS, INC.;SCIDOSE, LLC
发明人
TEJA, BULUSU BHANU;BUXTON, PHILIP CHRISTOPHER;PALEPU, NAGESH R.
